Status:
COMPLETED
Effects of Nasal-spraying LiveSpo Navax in Treatment of Influenza Virus in Children
Lead Sponsor:
National Children's Hospital, Vietnam
Conditions:
Acute Respiratory Tract Infections
Eligibility:
All Genders
4-7 years
Phase:
NA
Brief Summary
Acute Respiratory Tract Infections (ARTIs) in children are common diseases, with influenza virus types A and B is one of the main causes of serious symptoms in young children. Although an influenza va...
Detailed Description
Influenza virus types A and B is the common virus that causes Acute Respiratory Tract Infections (ARTIs) with a high risk of bronchiolitis for young children and infants. Influenza-infection symptoms ...
Eligibility Criteria
Inclusion
- Children (male/female) aged from 4 months to 7 years
- Admitted to hospital due to upper respiratory infection
- Influenza A and B positive by rapid test
- Parents of the pediatric patient agree to participate in the study, explain and sign the research consent form.
Exclusion
- Newborn babies
- Having a history of drug allergies
- Need oxygen therapy
- Discharged before day 2
- Lost to follow-up
- Withdrawn from the trial
- Continuing in the trial but missing data
- Meeting the criteria for psychiatric disorders other than depression and/or anxiety.
Key Trial Info
Start Date :
December 21 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 22 2022
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT05378022
Start Date
December 21 2020
End Date
April 22 2022
Last Update
May 24 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
International Center, Vietnam National Children's Hospital
Hanoi, Vietnam, 100000